Last reviewed · How we verify
NCT03543943
Achilles Tendon Elongation and Gait Pattern After Rupture.
NA trial testing Individualized treatment of Acute Achilles tendon rupture. in Achilles Tendon Rupture in 60 participants. Completed in 10 December 2020.
10 December 2020
Quick facts
| Lead sponsor | Hvidovre University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 4 June 2018 |
| Primary completion | 10 December 2020 |
| Estimated completion | 10 December 2020 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Individualized treatment of Acute Achilles tendon rupture.
- Non-operative treatment
- Operative treatment
Conditions studied
- Achilles Tendon Rupture — all drugs for Achilles Tendon Rupture →
Sponsor
Hvidovre University Hospital
Who can join
Adults 18 to 65, any sex, with Achilles Tendon Rupture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to determine if Achilles tendon elongation and gait pattern differ between patients treated using an individualized treatment algorithm and patients treated as usual (two control groups; patients treated operatively and non-operatively). The individualized treatment algorithm is based on ultrasonographic status of tendon overlap and Copenhagen Achilles Length Measure (1). Patients are allocated for operative treatment if there the tendon overlap is less than 25 % or the tendon is elongated with 7% or more compared to the healthy, contralateral achilles tendon.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Individualized treatment for acute Achilles tendon rupture based on the Copenhagen Achilles Rupture Treatment Algorithm (CARTA): a study protocol for a multicenter randomized controlled trial.
Hansen MS, Vestermark MT, Hölmich P, Kristensen MT, et al · · 2020 · cited 7× · PMID 32398120 · DOI 10.1186/s13063-020-04332-z
Verify or expand the search:
- PubMed search for NCT03543943
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Individualized treatment of Acute Achilles tendon rupture.
Trials testing the same drug.
- NCT03525964 — Individualized Treatment of Acute Achilles Tendon Rupture · NA · completed
Other recruiting trials for Achilles Tendon Rupture
Currently open trials in the same condition.
- NCT07498166 — Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupt · NA · active not recruiting
- NCT07453485 — Immediate Effects of Neuromuscular Electrical Stimulation on Pain and Function in Achilles Tendon Disorders · NA · recruiting
- NCT07130357 — The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair · NA · recruiting
- NCT06723639 — Restoring Anatomy of Ruptured Achilles Tendon · NA · recruiting
- NCT06434272 — Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture · NA · recruiting
Other Hvidovre University Hospital trials
Trials by the same sponsor.
- NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
- NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
- NCT07054216 — Probiotic for Infants · NA · recruiting
- NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
- NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03543943 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
- Last refreshed: 16 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543943.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing